MODERNA, INC.

MRNA
Delayed Quote. Delayed  - 08/11 04:00:00 pm
171.81USD -1.41%

BioNTech, Pfizer to starting testing universal coronavirus vaccine in H2

06/29/2022 | 08:00am

June 29 (Reuters) - Germany's BioNTech, Pfizer's partner in COVID-19 vaccines, said the two companies would start tests on humans of next-generation shots that protect against a wide variety of coronaviruses in the second half of the year.

Their experimental work on shots that go beyond the current approach include T-cell enhancing shots, designed to primarily protect against severe disease if the virus becomes more dangerous, and pan-coronavirus shots that protect against the broader family of viruses and its mutations.

The two partners, makers of the Western world's most widely used COVID-19 shot, are currently discussing with regulators enhanced versions of their established shot to better protect against the Omicron variant and its sublineages.

(Reporting by Ludwig Burger and Patricia Weiss)

© Reuters 2022
Copier lien
All news about MODERNA, INC.
14h ago
17h ago
20h ago
2d ago
2d ago